From Tol2Kit
Jump to: navigation, search
Line 1: Line 1:
 
Here is a list of the constructs in the Tol2kit.
 
Here is a list of the constructs in the Tol2kit.
Sequences and maps coming Real Soon Now.
+
Sequences and maps coming Real Soon Now (we have complete sequences but need to annotate them).
  
 
'''Constructs in the Tol2kit v1 (Feb 2007)'''
 
'''Constructs in the Tol2kit v1 (Feb 2007)'''
Line 113: Line 113:
 
** EF, Esther Fujimoto, Chien lab
 
** EF, Esther Fujimoto, Chien lab
 
** KMK, Kristen Kwan, Chien lab
 
** KMK, Kristen Kwan, Chien lab
** MEH, Melissa Hardy
+
** MEH, Melissa Hardy, Chien lab
 
* pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed.
 
* pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed.

Revision as of 19:08, 6 February 2007

Here is a list of the constructs in the Tol2kit. Sequences and maps coming Real Soon Now (we have complete sequences but need to annotate them).

Constructs in the Tol2kit v1 (Feb 2007)

# name insert made by
5' entry clones, attL4-R1 (kan resistant)
299 p5E-bactin2 5.3 kb beta-actin promoter (ubiquitous) KMK
380 p5E-h2afx 1 kb histone2A-X promoter (quasi-ubiquitous) KMK
382 p5E-CMV/SP6 1 kb CMV/SP6 cassette from pCS2+ KMK
222 p5E-hsp70 1.5 kb hsp70 promoter for heat-shock induction BM
327 p5E-UASE1B 10x UAS element and basal promoter for Gal4 response DSC
228 p5E-MCS multi-cloning site from pBluescript BM
381 p5E-Fse-Asc restriction sites for 8-cutters FseI and AscI EF
middle entry clones, attL1-L2 (kan resistant)
383 pME-EGFP EGFP KMK
384 pME-EGFPCAAX membrane-localized (prenylated_ EGFP; fused to 21 aa of H-ras KMK
385 pME-nlsEGFP nuclear-localized EGFP KMK
386 pME-mCherry monomeric red fluorophore mCherry KMK
232 pME-mCherryCAAX prenylated mCherry KMK
233 pME-nlsmCherry nuclear-localized mCherry KMK
234 pME-H2AmCherry mCherry fused to zebrafish histone H2A.F/Z KMK
387 pME-Gal4VP16 Gal4 DNA binding domain fused to VP16 transactivation domain KMK
3' entry clones, attR2-L3 (kan resistant)
302 p3E-polyA SV40 late polyA signal KMK
229 p3E-MTpA 6x myc tag for C-terminal fusions, plus SV40 late polyA BM
366 p3E-EGFPpA EGFP for C-terminal fusions, plus SV40 late polyA MEH
388 p3E-mCherrypA mCherry for C-terminal fusions, plus SV40 late polyA MEH
389 p3E-IRES-EGFPpA IRES driving EGFP plus SV40 late polyA KMK
390 p3E-IRES-EGFPCAAXpA IRES driving prenylated EGFP plus SV40 late polyA KMK
391 p3E-IRES-nlsEGFPpA IRES driving nuclear EGFP plus SV40 late polyA KMK
destination vectors, attR4-R3 (amp/chlor resistant; grow in ccdB-tolerant cells)
392 pDestTol2pA* attR4-R3 gate with SV40 polyA flanked by Tol2 inverted repeats CG
393 pDestTol2CG* pDestTol2pA with cmlc2:egfp transgenesis marker EF
394 pDestTol2pA2 pDestTol2pA with ~2 kb extraneous sequence removed EF
395 pDestTol2CG2 pDestTol2CG2 with ~2 kb extraneous sequence removed EF
transposase clones
396 pCS2FA-transposase for in vitro transcription of capped Tol2 transposase mRNA KMK

Notes

  • # is the Chien lab stock number
  • made by shows who made the construct:
    • CG: Clemens Grabher, Look lab
    • BM: Ben Mangum, Chien lab
    • DSC, Doug Campbell, Chien lab
    • EF, Esther Fujimoto, Chien lab
    • KMK, Kristen Kwan, Chien lab
    • MEH, Melissa Hardy, Chien lab
  • pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed.